Order Article Reprints

Šťastná-Marková M, Hamšíková E, Hainz P, Hubáček P, Kroutilová M, Kryštofová J, Ludvíková V, Musil J, Pecherková P, Saláková M, et al. Pretransplant BK Virus-Specific T-Cell-Mediated Immunity and Serotype Specific Antibodies May Have Utility in Identifying Patients at Risk of BK Virus-Associated Haemorrhagic Cystitis after Allogeneic HSCT. Vaccines. 2021; 9(11):1226. https://doi.org/10.3390/vaccines9111226

Šťastná-Marková, Markéta, Eva Hamšíková, Petr Hainz, Petr Hubáček, Marie Kroutilová, Jitka Kryštofová, Viera Ludvíková, Jan Musil, Pavla Pecherková, Martina Saláková, and et al. 2021. "Pretransplant BK Virus-Specific T-Cell-Mediated Immunity and Serotype Specific Antibodies May Have Utility in Identifying Patients at Risk of BK Virus-Associated Haemorrhagic Cystitis after Allogeneic HSCT" Vaccines 9, no. 11: 1226. https://doi.org/10.3390/vaccines9111226

Šťastná-Marková, M., Hamšíková, E., Hainz, P., Hubáček, P., Kroutilová, M., Kryštofová, J., Ludvíková, V., Musil, J., Pecherková, P., Saláková, M., Šroller, V., Vydra, J., & Němečková, Š. (2021). Pretransplant BK Virus-Specific T-Cell-Mediated Immunity and Serotype Specific Antibodies May Have Utility in Identifying Patients at Risk of BK Virus-Associated Haemorrhagic Cystitis after Allogeneic HSCT. Vaccines, 9(11), 1226. https://doi.org/10.3390/vaccines9111226